Optimizing the Treatment Strategy for Age-related Macular Degeneration
Condition(s):Wet Macular DegenerationLast Updated:December 29, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):Wet Macular DegenerationLast Updated:December 29, 2023Recruiting
Condition(s):Exudative Age Related Macular DegenerationLast Updated:October 22, 2020Completed
Condition(s):Macular DegenerationLast Updated:March 21, 2022Completed
Condition(s):Age Related Macular DegenerationLast Updated:September 2, 2021Completed
Condition(s):Neovascular Age-related Macular DegenerationLast Updated:May 23, 2023Completed
Condition(s):Age-related Macular DegenerationLast Updated:September 23, 2021Completed
Condition(s):Age-Related Macular DegenerationLast Updated:November 9, 2017Completed
Condition(s):Wet Age-related Macular DegenerationLast Updated:March 31, 2016Withdrawn
Condition(s):Macular DegenerationLast Updated:January 8, 2018Completed
Condition(s):Age-Related Macular Degeneration; Neovascular Age-related Macular DegenerationLast Updated:February 14, 2023Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.